EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
03.03.23
/
50%
€2.92
Target price
03.03.24
€19.79
Performance (%)
797.26%
End price
04.03.24
€26.20
Summary
This prediction ended on 04.03.24 with a price of €26.20. The BUY prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc. saw massive gains of 797.26%. Chardan_Capital has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 2.720% | 2.720% | 107.890% |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
03.08.23
03.08.23
€20.11
03.08.24
03.08.24
-2.04%
13.05.24
13.05.24
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€25.98
07.05.25
07.05.25
14.26%
13.05.24
13.05.24